CLINICAL_TRIALS
trial_result
· 2020-09-03
Clinical Trial Update: Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea [Phase 3]
Summary
Phase 3 trial evaluating safety and effectiveness of three doses of crofelemer versus placebo for HIV-associated diarrhea completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bausch Health Americas, Inc. | Conditions: HIV Associated Diarrhea | Phase 3 | Status: COMPLETED | Results posted: 2020-09-03